PATRICIA ESMERALDA
CARREIRA DELGADO
Profesora asociada de Ciencias de la Salud
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (19)
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease
Clinical Rheumatology, Vol. 38, Núm. 3, pp. 803-815
2016
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the spanish rheumatology society lupus registry (RELESSER) with emphasis on complete versus incomplete lupus differences
Medicine (United States), Vol. 94, Núm. 1, pp. e267
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis
American Journal of Human Genetics, Vol. 94, Núm. 1, pp. 47-61
-
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus
Arthritis Research and Therapy, Vol. 16, Núm. 3
2013
2012
-
Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
Arthritis Research and Therapy, Vol. 14, Núm. 3
-
Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis
Journal of Rheumatology, Vol. 39, Núm. 6, pp. 1275-1279
-
Influence of the IL6 gene in susceptibility to systemic sclerosis
Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302
-
Inhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation
Arthritis and Rheumatism, Vol. 64, Núm. 5, pp. 1653-1664
-
No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis
Tissue Antigens, Vol. 80, Núm. 3, pp. 254-258
-
The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis
Genes and Immunity, Vol. 13, Núm. 2, pp. 191-196
2011
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology
1997
-
Antiphospholipid antibodies in patients with eosinophilia myalgia and toxic oil syndrome
Journal of Rheumatology, Vol. 24, Núm. 1, pp. 69-72
-
Apoptosis and proliferation of fibroblasts during postnatal skin development and scleroderma in the tight-skin mouse
Journal of Histochemistry and Cytochemistry, Vol. 45, Núm. 5, pp. 711-719